DrugPatentWatch Database Preview
Acelrx Pharms Company Profile
What is the competitive landscape for ACELRX PHARMS, and what generic alternatives to ACELRX PHARMS drugs are available?
ACELRX PHARMS has one approved drug.
There are fourteen US patents protecting ACELRX PHARMS drugs.
There are seventy-nine patent family members on ACELRX PHARMS drugs in nineteen countries and three supplementary protection certificates in two countries.
Summary for Acelrx Pharms
| International Patents: | 79 |
| US Patents: | 14 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Acelrx Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | 8,202,535 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | 8,226,978 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | 8,865,743 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | 9,320,710 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | 8,945,592 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | 8,535,714 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | 8,778,393 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Acelrx Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 5349053 | ➤ Try a Free Trial |
| European Patent Office | 2114383 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2008085763 | ➤ Try a Free Trial |
| Germany | 602007007991 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2008085764 | ➤ Try a Free Trial |
| Spain | 2408323 | ➤ Try a Free Trial |
| Canada | 2673856 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for Acelrx Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2114383 | CA 2016 00007 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: SUFENTANIL, HERUNDER SUFENTANIL SOM CITRAT; REG. NO/DATE: EU/1/15/1042/001-006 20150922 |
| 2114383 | 300797 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: SUFENTANIL, DESGEWENST IN DE VORM VAN SUFENTANILCITRAAT; REGISTRATION NO/DATE: EU/1/15/1042 20150922 |
| 2114383 | CR 2016 00007 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: SUFENTANIL; REG. NO/DATE: EU/1/15/1042/001-006 20150922 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
